INMUNE BIO INC. (INMB) Operating income 2017–2025
INMUNE BIO INC. (INMB) annual operating income history from SEC filings — each fiscal year as reported.
-$47.4MFY2025 · since FY2017: -$981,480 → -$47.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$47.4M | -11.1% |
| FY2024 | -$42.6M | -43.4% |
| FY2023 | -$29.7M | -14.6% |
| FY2022 | -$26.0M | +11.0% |
| FY2021 | -$29.2M | -138.4% |
| FY2020 | -$12.2M | -57.7% |
| FY2019 | -$7.8M | +37.7% |
| FY2018 | -$12.4M | -1167.5% |
| FY2017 | -$981,480 | — |
Source: SEC XBRL filings · For reference only · Not investment advice